2024 annual financial data
Aldeyra Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -60,117,032 USD and net income was -55,851,444 USD.
Operating cash flow was -43,208,747 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -60,117,032 USD
- Net income
- -55,851,444 USD
- Operating cash flow
- -43,208,747 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Aldeyra Therapeutics financial years